Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" study

被引：1
|
作者：
Prete, Alessandra Anna
Manca, Paolo
Morano, Federica
Rasola, Cosimo
Messina, Marco
Formica, Vincenzo
Corsi, Domenico Cristiano
Cortesi, Enrico
Frassineti, Giovanni Luca
Zampino, M. Giulia
Casagrande, Mariaelena
Masi, Gianluca
Ronzoni, Monica
Scartozzi, Mario
Prisciandaro, Michele
Bergamo, Francesca
Vettore, Valentina
Pietrantonio, Filippo
Fassan, Matteo
Lonardi, Sara
机构：
[1] Veneto Inst Oncol IOV IRCCS, Dept Oncol Oncol 1, Padua, Italy
[2] Ist Nazl Tumori, Milan, Italy
[3] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, ENETS Ctr Excellence, Milan, Italy
[4] Univ Padua, Unit Surg Oncol & Gastroenterol, Padua, Italy
[5] UOC Oncol Fdn Ist G Giglio, Palermo, Italy
[6] Tor Vergata Univ, Med Oncol Unit, Rome, Italy
[7] Osped San Giovanni Calibita Fatebenefratelli, Med Oncol Unit, Rome, Italy
[8] Sapienza Univ Rome, Rome, Italy
[9] IRCCS, Med Oncol Unit, Ist Sci Romagnolo Studio Cura Tumori IRST, Meldola, Italy
[10] IRCCS, Ist Europeo Oncol, Div Oncol Med Gastrointestinale & Tumori Neurodoc, Milan, Italy
[11] Azienda Sanitaria Univ Integrata Udine, Dept Oncol, Udine, Italy
[12] Azienda Osped Univ Pisana, Pisa, Italy
[13] Ist Sci San Raffaele IRCSS, Dept Oncol, Milan, Italy
[14] Univ Hosp, Med Oncol Unit, Cagliari, Italy
[15] Univ Cagliari, Cagliari, Italy
[16] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[17] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[18] Univ Hosp Padua, Dept Pathol, Padua, Italy
[19] Veneto Inst Oncol IOV IRCCS, Padua, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
    Huffman, Brandon M.
    Singh, Harshabad
    Ali, Lestat R.
    Horick, Nora
    Wang, S. Jennifer
    Hoffman, Megan T.
    Metayer, Katherine A.
    Murray, Shayla
    Bird, Alexandra
    Abrams, Thomas A.
    Biller, Leah H.
    Chan, Jennifer A.
    Meyerhardt, Jeffrey A.
    Mccleary, Nadine J.
    Goessling, Wolfram
    Patel, Anuj K.
    Wisch, Jeffrey S.
    Yurgelun, Matthew B.
    Mouw, Kent
    Reardon, Brendan
    Van Allen, Eliezer M.
    Zerillo, Jessica A.
    Clark, Jeffrey W.
    Parikh, Aparna
    Mayer, Robert J.
    Schlechter, Benjamin
    Ng, Kimmie
    Kumar, Sunil
    Fitz, Catherine Del Vecchio
    Kuperwasser, Charlotte
    Hanna, Glenn J.
    Coveler, Andrew L.
    Rubinson, Douglas A.
    Welsh, Emma L.
    Pfaff, Kathleen
    Rodig, Scott
    Dougan, Stephanie K.
    Cleary, James M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (01)
  • [32] Molecular analyses of metastatic collecting ducts renal cell carcinoma from the phase 2 prospective trial of cabozantinib as first-line treatment (BONSAI trial Meeturo 2).
    Todoerti, Katia
    Sepe, Pierangela
    Andrea, Devecchi
    Busico, Adele
    Agnelli, Luca
    Perrone, Federica
    Gargiuli, Chiara
    Dugo, Matteo
    De Cecco, Loris
    Claps, Melanie
    Fotia, Giuseppe
    Guadalupi, Valentina
    Verzoni, Elena
    Procopio, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16507 - E16507
  • [33] Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)
    Ai, Dashan
    Chen, Yun
    Liu, Qi
    Deng, Jiaying
    Zhang, Xiaofei
    Zhang, Junhua
    Chu, Li
    Shen, Jingyi
    Ma, Longfei
    Zhang, Yawei
    Chen, Haiquan
    Miao, Longsheng
    Zhao, Kuaile
    Xiang, Jiaqing
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [34] Survival rate variation with different histological subtypes of poor prognostic male anal squamous cell carcinoma: a population-based study
    Wan, Zihao
    Huang, Zhihao
    Vikash, Vikash
    Rai, Kelash
    Vikash, Sindhu
    Chen, Liaobin
    Li, Jingfeng
    ONCOTARGET, 2017, 8 (48) : 84349 - 84359
  • [35] Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)
    Dashan Ai
    Yun Chen
    Qi Liu
    Jiaying Deng
    Xiaofei Zhang
    Junhua Zhang
    Li Chu
    Jingyi Shen
    Longfei Ma
    Yawei Zhang
    Haiquan Chen
    Longsheng Miao
    Kuaile Zhao
    Jiaqing Xiang
    Radiation Oncology, 18
  • [36] Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix - A gynecologic oncology group study
    Garcia, Agustin A.
    Blessing, John A.
    Vaccarello, Luis
    Roman, Lynda D.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (04): : 428 - 431
  • [37] Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: Nine Japanese institutions trial
    Ishida, K
    Iizuka, T
    Ando, N
    Ide, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1996, 26 (05) : 310 - 315
  • [38] Phase II trial of bevacizumab in the treatment of recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
    Monk, B. J.
    Sill, M. W.
    Burger, R. A.
    Gray, H. J.
    Buekers, T. E.
    Roman, L. D.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S21 - S22
  • [39] Pembrolizumab for previouslytreated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study
    Marabelle, Aurelien
    Cassier, Philippe A.
    Fakih, Marwan
    Kao, Steven
    Nielsen, Dorte
    Italiano, Antoine
    Guren, Tormod Kyrre
    van Dongen, Marloes G. J.
    Spencer, Kristen
    Bariani, Giovanni Mendonca
    Ascierto, Paolo A.
    Santoro, Armando
    Shah, Manisha
    Asselah, Jamil
    Iqbal, Syma
    Takahashi, Shunji
    Piha-Paul, Sarina A.
    Ott, Patrick A.
    Chatterjee, Arkendu
    Jin, Fan
    Norwood, Kevin
    Delord, Jean-Pierre
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (05): : 446 - 454
  • [40] NCI#9673 phase II study of nivolumab in refractory metastatic squamous cell carcinoma of the anal canal: Immunologic correlates of response
    Morris, Van
    Mahvash, Armeen
    Vence, Luis
    Blando, Jorge
    Wolff, Robert A.
    Ohinata, Aki
    Ohaji, Chimela
    Allison, James
    Sharma, Padmanee
    Eng, Cathy
    CANCER RESEARCH, 2016, 76
12345